Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosisAntoine Gavoille, Mikail Nourredine, Fabien Rollot, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Brain : a Journal of Neurology|February 14, 2026
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosisFabien Rollot, Romain Casey, Anne Kerbrat, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 3, 2025
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
JAMA Neurology|July 1, 2024
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
American Journal of Ophthalmology|February 23, 2023
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J Chen, Eoin P Flanagan, Sean J Pittock, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
JAMA Neurology|March 23, 2026
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseMarine Boudot de la Motte, Antoine Gavoille, Caroline Papeix, et al.
Neurology|August 29, 2025
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseSmathorn Thakolwiboon, Vyanka Redenbaugh, Bo Chen, et al.
Pageof 14